Nika Financial Statements From 2010 to 2025
| NIKA Stock | USD 0.28 0.00 0.00% |
Check Nika BioTechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nika BioTechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nika financial statements analysis is a perfect complement when working with Nika BioTechnology Valuation or Volatility modules.
Nika |
Nika BioTechnology Company Number Of Employees Analysis
Nika BioTechnology's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Nika BioTechnology Number Of Employees | 4 |
Most of Nika BioTechnology's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nika BioTechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Nika BioTechnology is currently employing 4.0 people. This is 99.96% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The number of employees for all United States stocks is 99.98% higher than that of the company.
About Nika BioTechnology Financial Statements
Nika BioTechnology stakeholders use historical fundamental indicators, such as Nika BioTechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nika BioTechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nika BioTechnology's assets and liabilities are reflected in the revenues and expenses on Nika BioTechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nika BioTechnology. Please read more on our technical analysis and fundamental analysis pages.
International Professional Trainings Group Limited provides online and face-to-face under-graduate and graduate university studies, professional training, study tours, and consulting services. The company was incorporated in 1999 and is based in North Las Vegas, Nevada. Nika Biotechnology is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nika Pink Sheet
Nika BioTechnology financial ratios help investors to determine whether Nika Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nika with respect to the benefits of owning Nika BioTechnology security.